Efficacy of Centanafadine SR as a Potential Smoking Cessation Treatment
Clinical trial NCT05066724 · COMPLETED
Trial details
- NCT number
- NCT05066724
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-15
- Primary completion
- 2022-05-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.